Cyndeo Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Cyndeo Wealth Partners's BMY Position: Q2 2026 in Review
Cyndeo Wealth Partners increased its Bristol-Myers Squibb (BMY) stake by 6.2% in Q2 2026, buying an estimated $620K and bringing the position to 186,460 shares worth $10.7M. The position accounts for 0.51% of the portfolio, ranked #62.
Cyndeo Wealth Partners first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. 814 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Cyndeo Wealth Partners held 186,460 shares of Bristol-Myers Squibb worth $10.7M as of Q2 2026.
- Cyndeo Wealth Partners bought 10,803 Bristol-Myers Squibb shares in Q2 2026, an estimated $620K.
- Bristol-Myers Squibb made up 0.51% of Cyndeo Wealth Partners's portfolio in Q2 2026, its #62 holding.
- Cyndeo Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
- 814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Cyndeo Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.